|
COURAGE-2 Study |
|
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer |
|
VALERGEN-combination of routes- Asthma-Adults-Phase II |
|
Melagenina Plus - Vitiligo – phase IV |
|
Combifer-T, Trofin and Ferrous Fumarate in iron-deficiency anemia in pregnant women. |
|
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) |
|
Colilen IBS- Irritable Bowel Syndrome- adults-Phase III |
|
Effectiveness of a case management model for the comprehensive provision of health services to pluripathological patients |
|
DENIS Study |
|
CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial |
|
Nimotuzumab cold kit for the immunodiagnosis of solid tumors |
|
Topic Oleozon in patients with epidermophytosis |
|
Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III. |
|
VSSP in metastasic renal cell carcinoma |
|
AMIGOS-2 study |
|
CERVICONC-II-300 study |
|
CIMAvax-EGF-Platelets-Adults- Lung Cancer |
|
HeberNasvac® Phase IV in Chronic Hepatitis B |
|
NeuroEPO in stroke |
|
Oncoxin-Viusid / Pancreatic adenocarcinoma / Adults / Phase II |
